EKF Diagnostics Holdings Plc acquires Quotient Diagnostics Limited
EKF Diagnostics Holdings plc (AIM: EKF), which has recently refocused on the in-vitro diagnostic devices market, acquired the entire issue share capital of Quotient Diagnostics Limited ("Quotient") on 4th October 2010.
Quotient Diagnostics secures investment, wins award, and advances sales
The new funding will enable Quotient to expand production and accelerate distribution.
Quotient Diagnostics Secures £1 Million Funding to Move into Production
New technology Quot-Test will provide significantly faster and cheaper diabetes testing.
Reevoo Secures Investment from Banexi Ventures Partners
Investment earmarked for acceleration of international expansion ahead of expected second funding round.
IQ Capital Partners LLP is authorised and regulated by the Financial Conduct Authority
Registered Office - 85 Regent Street, Cambridge, CB2 1AW
Registration No: OC331235 VAT Registered: 918046327
© IQ Capital Partners LLP 2016
Submit a Proposal
website by Koala